Description
THREE PHASES OF MEDICATION TESTING
First action · last action
2023-09-25 · 2023-09-25
Transactions
1
First transaction's obligation
$98,571
Base + all options value (sum of deltas)
$98,571
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-09-25+$98,571= $98,571
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-09-25 | +$98,571 | $98,571 | THREE PHASES OF MEDICATION TESTING |
Related awards · 2
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other recipients under AN11 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24924C0020 | RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $121,056 | FY2024 |
| 36C24921P0420 | NOVOGENE CORPORATION INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $9,072 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24923P1000_3600_-NONE-_-NONE- · retrieved 2026-09-26.